This was nothing more than a procedural move as Megill is set to miss the entire 2026 season after undergoing Tommy John reconstructive elbow surgery in September. Making the move now clears a spot on the club’s 40-man roster for MJ Melendez who was officially signed on Thursday.
NBC Sports / Rotoworld
Latest player news
Source-authentic updates matched to the canonical StatPro player record.
The Mets could have non-tendered Megill, since he’s due to miss all of next season following Tommy John surgery in September, but they’re essentially betting he’ll be worth more than $5 million in 2027, which will be his final season before free agency.
Megill is likely to be sidelined until the 2027 season given the timing of the procedure, which typically carries a 12-14 month recovery timetable. The 30-year-old’s absence is a hit to New York’s starting pitching depth for the rest of the current season and next year as well.
It’s a hit to New York’s rotation and middle relief depth for the rest of the immediate campaign and next season as well considering both would likely be out until 2027 recovering from reconstructive surgeries. A final decision on their next steps should come at some point in the near future, but it sounds like both are facing extended absences.
4 news items shown
